The clinical utility of DNA-based screening for fetal aneuploidy by primary obstetrical care providers in the general pregnancy population.
about
cfDNA screening performance: accounting for and reducing test failures.Obstetrical provider knowledge and attitudes towards cell-free DNA screening: results of a cross-sectional national survey.Recent developments in genetics and medically assisted reproduction: from research to clinical applications
P2860
The clinical utility of DNA-based screening for fetal aneuploidy by primary obstetrical care providers in the general pregnancy population.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
The clinical utility of DNA-ba ...... general pregnancy population.
@en
The clinical utility of DNA-ba ...... general pregnancy population.
@nl
type
label
The clinical utility of DNA-ba ...... general pregnancy population.
@en
The clinical utility of DNA-ba ...... general pregnancy population.
@nl
prefLabel
The clinical utility of DNA-ba ...... general pregnancy population.
@en
The clinical utility of DNA-ba ...... general pregnancy population.
@nl
P2860
P50
P356
P1433
P1476
The clinical utility of DNA-ba ...... general pregnancy population.
@en
P2093
Barbara M O'Brien
Elizabeth E Eklund
P2860
P2888
P304
P356
10.1038/GIM.2016.194
P407
P577
2017-01-12T00:00:00Z
P6179
1026419487